Author

Hossein Javid

Observed name: Hosein Javid
ORCID: 0000-0002-2248-7708
Observed ORCID: 0000-0002-2248-7708
OpenAlex ID: A5078713580
2024 · Hossein Javid, Mahsa Akbari Oryani, et al. · Cancer Medicine · 303
2019 · Fariba Mohammadi, Arash Soltani, et al. · Cancer Chemotherapy and Pharmacology · 130
2019 · Erfan Tavana, Hamid Mollazadeh, et al. · BioFactors · 99
2023 · Farangis Rastin, Hossein Javid, et al. · International Immunopharmacology · 86
2020 · Amir R. Afshari, Mohammad Jalili-Nik, et al. · Current Medicinal Chemistry · 85
2019 · Hossein Javid, Fariba Mohammadi, et al. · Journal of Physiology and Biochemistry · 64
2024 · Mahsa Akbari Oryani, Mojtaba Tarin, et al. · Journal of drug targeting · 55
2022 · Soodabeh Rezaei, Reza Assaran Darban, et al. · BioMed Research International · 43
2023 · Farangis Rastin, Mahsa Akbari Oryani, et al. · Journal of Materials Chemistry B · 42
2025 · Mojtaba Tarin, Mahsa Akbari Oryani, et al. · International Immunopharmacology · 41
2022 · Mehdi Karimi-Shahri, Abbas Alalikhan, et al. · Nanotechnology · 41
2021 · Hamed Amiri, Seyed Isaac Hashemy, et al. · Research on Chemical Intermediates · 40
2022 · Hossein Javid, Pedram Hashemian, et al. · Journal of Cellular Biochemistry · 39
2023 · Mahboubeh Tajaldini, Amirhoushang Poorkhani, et al. · European Journal of Pharmacology · 38
2018 · Arash Soltani, Arash Salmaninejad, et al. · Journal of Cellular Physiology · 38
2023 · Samine Jafarinezhad, Reza Assaran Darban, et al. · Cell Biochemistry and Biophysics · 37
2023 · Mahsa Akbari Oryani, Shamim Nosrati, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 37
2022 · Mehdi Sanati, Maryam Moradi Binabaj, et al. · Biomedicine & Pharmacotherapy · 35
2021 · Faranak Korfi, Hossein Javid, et al. · Biochemistry Research International · 35
Works count: 81
Citation count: 2,187
H-index: 28
I10-index: 52
Year
Topic
Type